financetom
Business
financetom
/
Business
/
Ferrari to Introduce Cryptocurrency Payment System to European Dealers
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Ferrari to Introduce Cryptocurrency Payment System to European Dealers
Jul 24, 2024 8:07 AM

10:40 AM EDT, 07/24/2024 (MT Newswires) -- Ferrari ( RACE ) said Wednesday that it will extend its cryptocurrency payment system to its network of European dealers from the end of July.

The move follows the system's launch in the US less than a year ago, the company added.

Ferrari ( RACE ) said that by the end of 2024, it will make this alternative payment system available to other countries that legally accept cryptocurrencies.

The goal is to enable dealers to accept payments without handling cryptocurrencies directly, as these will be converted immediately into traditional currency, the company said.

Price: 417.18, Change: -5.99, Percent Change: -1.42

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BioRestorative Therapies' Q3 revenue drops, net loss widens
BioRestorative Therapies' Q3 revenue drops, net loss widens
Nov 12, 2025
Overview * BioRestorative Q3 2025 revenue declines significantly compared to Q3 2024 * Company reports Q3 net loss of $3 mln, up from $1 mln in Q3 2024 * BioRestorative strengthens financial position with recent stock offering and private placement Outlook * Company focuses on near-term revenue strategy in BioCosmeceutical platform * BioRestorative aims to expand BioCosmeceutical offerings for FDA...
Lyell Immunopharma Q3 adjusted net loss beats estimates
Lyell Immunopharma Q3 adjusted net loss beats estimates
Nov 12, 2025
Overview * Lyell Q3 adjusted net loss beats analyst expectations * Company acquired global rights to LYL273, a GCC-targeted CAR T-cell product * Initiated PiNACLE - H2H Phase 3 trial for aggressive large B-cell lymphoma Outlook * Company expects to begin PiNACLE - H2H trial enrollment by early 2026 * Lyell anticipates LYL273 Phase 1 trial data update in H1...
Crescent Capital's Q3 NAV per share falls
Crescent Capital's Q3 NAV per share falls
Nov 12, 2025
Overview * Crescent Capital BDC ( CCAP ) Q3 net investment income per share was $0.46, unchanged from Q2 * Net asset value per share declines to $19.28 from $20.20 year-over-year * Company declares Q4 regular cash dividend of $0.42 per share Outlook * Company has $239.8 mln undrawn capacity on credit facilities * Weighted average cost of debt is...
GRAIL Q3 Loss Narrows, Revenue Rises
GRAIL Q3 Loss Narrows, Revenue Rises
Nov 12, 2025
04:33 PM EST, 11/12/2025 (MT Newswires) -- GRAIL (GRAL) reported a Q3 net loss late Wednesday of $2.46 per diluted share, narrowing from the loss of $3.94 a year earlier. Four analysts polled by FactSet expected a loss of $3.37. Revenue in the three months ended Sept. 30 rose to $36.2 million from $28.7 million a year earlier. Three analysts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved